Journal Club #1: Update on Nonpsychotic Unipolar Depression Management

We begin PEFA Journal Club’s updated schedule with our first journal club discussion today:

Journal Club #1:

The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Update on Unipolar Nonpsychotic Depression.

Article: Harv Rev Psychiatry. 2019 Jan/Feb;27(1):33-52. PMID: 30614886.

This 45 minutes journal club video discussion will answer the following 11 clinically relevant questions:

  1. Which medications are first-line treatment options in the management of MDD [in outpatient setting]? 
  2. What are the next step options after the first-line treatment fails (poor or no response): Augmentation options?
  3. What are the next step options after the first-line treatment fails (poor or no response): Switching options?
  4. Management options for Treatment-Resistant Depression without comorbidities.
  5. Management options for Treatment-Resistant Depression with and without Atypical Features.
  6. Management options for Treatment-Resistant Depression with Medical Comorbidities.
  7. Management options for Treatment-Resistant Depression with Chronic Pain.
  8. Management options for Treatment-Resistant Depression with OCD.
  9. Management options for Treatment-Resistant Depression with ADHD.
  10. Management options for Treatment-Resistant Depression with PTSD.
  11. How to manage Severe Melancholic Depression [in Inpatient Settings]?

FOR PEFA MEMBERS ONLY:

Psychiatry Education Forum’s Journal Club is an additional feature for PEF Academy’s members. All academy members will be automatically enrolled in this journal club.

Here we post the most recently published psychiatry articles relevant to your daily clinical practice with CME credits available for selective journal club activities. 

PEFA Journal Club’s updated schedule (from June 13 to June 24, 2021) will contain the following 13 clinically relevant topics discussion & access to 4.75 AMA PRA Category 1 CME Credits (available from June 26, 2021).

MAJOR DEPRESSIVE DISORDER: GUIDELINES UPDATE

Journal Club #1: (June 13, 2021) 

Update on Nonpsychotic Unipolar Depression: Psychopharmacology Algorithm Project.

Psychother Psychosom. 2019;88(5):263-273

Journal Club #2: (June 14, 2021)

Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder.

Psychother Psychosom. 2019;88(5):263-273

BIPOLAR DISORDER: GUIDELINES UPDATE

Journal Club #3: (June 15, 2021)

Bipolar Depression Update: CANMAT & ISBD (2018) Vs Psychopharmacology Algorithm Project Update (2019) Guidelines

Harv Rev Psychiatry. 2010 Jan-Feb;18(1):36-55.5

SCHIZOPHRENIA

Journal Club #4: (June 16, 2021)

Staging of Schizophrenia With the Use of PANSS: An International Multi-Center Study.

Int J Neuropsychopharmacol. 2019 Nov 1;22(11):681-697

Journal Club #5: (June 17, 2021)

Comparing 32 Oral Antipsychotics for Acute Multi-Episode Schizophrenia Treatment.

Lancet. 2019;394(10202):939-951.

Journal Club #6: (June 18, 2021)

Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: Randomized Clinical Trial.

JAMA Psychiatry . 2020 Apr 1;77(4):349-358.

Journal Club #7: (June 18, 2021)

Non-D2-Receptor-Binding Medication for Schizophrenia.

N Engl J Med. 2020 Apr 16;382(16):1497-1506.

PSYCHOPHARMACOLOGY: ADVERSE EVENTS

Journal Club #8: (June 19, 2021)

Vortioxetine for Emotional Blunting in patients with Inadequate Response to SSRI/SNRI.

Psychother Psychosom. 2019;88(5):263-273

Journal Club #9: (June 20, 2021)

Adjunctive Metformin for Antipsychotic-Induced Dyslipidemia: Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials.

Transl Psychiatry. 2020 Apr 23;10(1):117.

Journal Club #10: (June 21, 2021)

Almost all Antipsychotics Result in Weight Gain: Meta-Analysis.

PLoS One. 2014 Apr 24;9(4):e94112

PSYCHOPHARMACOLOGY: SAFETY RISKS

Journal Club #11: (June 22, 2021)

Associations of Benzodiazepines, Z-Drugs, and Other Anxiolytics With Subsequent Dementia in Patients With Affective Disorders

Am J Psychiatry. 2020 Jun 1;177(6):497-505.

Journal Club #12: (CME Credits not Available for this Journal Club): June 23, 2021

Is Ketamine Safe with History of Psychosis?

JAMA Network Open. 2020 May; 3(5): e204693

PTSD (POST-TRAUMATIC STRESS DISORDER)

Journal Club #13: (June 24, 2021)

International Trauma Questionnaire to assess Post-Traumatic Stress Disorder (PTSD) & Complex PTSD.

Br J Psychiatry. 2020;216(3):132‐137.

CME ACCREDITATION:

4.75 AMA PRA Category 1 Credits Available from June 26, 2021

→ CME Credits will increase with our upcoming journal club video discussions.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute, LLC and Psychiatry Education Forum LLC. The PeerPoint Medical Education Institute, LLC is accredited by the ACCME to provide continuing medical education for physicians.

The PeerPoint Medical Education Institute, LLC designates this enduring activity for a maximum of 4.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation & Designation Statements and Disclosure Report:

INTERESTED IN JOINING THIS JOURNAL CLUB DISCUSSION SERIES?

JOIN PSYCHIATRY EDUCATION FORUM ACADEMY MEMBERSHIP

This is a closed membership for medical professionals only.

  • 30+ Courses/Sections: Each chapter within these sections is of direct clinical relevance for your daily practice. 
  • Journal Club: we will post the most recently published psychiatry articles relevant to your daily clinical practice.
  • Coffee Club: contain short discussions with clinical experts in the field of psychiatry.
  • Essentials of Inpatient Psychiatry Book: All chapters from this book are included in the academy sections. 
  • Discussion Forum & Community: Connect with other medical professionals and discuss your difficult-to-treat clinical cases.
  • Conference Discounts: Academy members get discounted access at our conferences. 
  • Goal: is to have all important clinically relevant topics in one place for ease of access.
 

SUBSCRIBE TO OUR EMAIL NEWSLETTER:

Related Articles